Lasota J, Franssila K, Koo C H, Miettinen M
Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Mod Pathol. 1996 Apr;9(4):361-6.
Mantle cell lymphoma (formerly known as intermediate lymphocytic lymphoma, diffuse centrocytic lymphoma, or diffuse small cleaved lymphoma) is one of the small cell non-Hodgkin lymphoma entities that is clinically more aggressive than small lymphocytic lymphoma, and needs to be separated from it. Mantle cell lymphoma is strongly associated with the t(11;14) chromosomal translocation that rearranges the bcl-1 oncogene (PRAD-1 gene) and immunoglobulin heavy chain gene. In this study, we developed a nested polymerase chain reaction system to evaluate the t(11;14) translocation. The study material consisted of 10 mantle cell lymphomas fulfilling the criteria suggested by other authors (P. M. Banks et al. Surg Pathol 16:637, 1992). A novel nested polymerase chain reaction system was used to evaluate the bcl-1 breaks in the major translocation cluster using two successive polymerase chain reaction amplifications. This reaction yielded a background-free single product of the size of 200 to 300 base pairs in four of 10 mantle cell lymphomas. The identity of the product from the nested polymerase chain reaction was confirmed by Southern blotting followed by hybridization with a specific probe. The amplification products were also evaluated by Sst-I, Alu-I, Dde-I, and Ita-I restriction enzymes and showed different patterns of digestion reflecting individual differences between the MTC/ IgH junctions. A selection of other low-grade lymphomas, including lymphocytic, follicular, and mucosa-associated lymphoid tissue lymphoma, and hairy cell leukemia and 29 hyperplastic lymph nodes were negative. This nested polymerase chain reaction system for the t(11;14) translocation involving major translocation cluster offers a convenient specific identification for mantle cell lymphoma. However, this test has a limited diagnostic power because only about half of the mantle cell lymphomas show the bcl-1 breaks in the major translocation cluster. The test performs well in formaldehyde-fixed and paraffin-embedded material, allowing the study of large numbers of retrospective cases of mantle cell lymphomas.
套细胞淋巴瘤(以前称为中等淋巴细胞淋巴瘤、弥漫性中心细胞淋巴瘤或弥漫性小裂细胞淋巴瘤)是小细胞非霍奇金淋巴瘤的一种,临床上比小淋巴细胞淋巴瘤侵袭性更强,需要与之区分开来。套细胞淋巴瘤与t(11;14)染色体易位密切相关,该易位会使bcl-1癌基因(PRAD-1基因)和免疫球蛋白重链基因发生重排。在本研究中,我们开发了一种巢式聚合酶链反应系统来评估t(11;14)易位。研究材料包括10例符合其他作者(P.M. Banks等人,《外科病理学》16:637,1992)建议标准的套细胞淋巴瘤。使用一种新型巢式聚合酶链反应系统,通过两次连续的聚合酶链反应扩增来评估主要易位簇中的bcl-1断裂情况。该反应在10例套细胞淋巴瘤中的4例中产生了大小为200至300个碱基对的无背景单一产物。通过Southern印迹法,然后与特异性探针杂交,确认了巢式聚合酶链反应产物的身份。扩增产物还通过Sst-I、Alu-I、Dde-I和Ita-I限制性内切酶进行评估,显示出不同的消化模式,反映了MTC/IgH连接点之间的个体差异。选择的其他低级别淋巴瘤,包括淋巴细胞性、滤泡性和黏膜相关淋巴组织淋巴瘤,以及毛细胞白血病和29个增生性淋巴结均为阴性。这种涉及主要易位簇的t(11;14)易位的巢式聚合酶链反应系统为套细胞淋巴瘤提供了一种方便的特异性鉴定方法。然而,该检测的诊断能力有限,因为只有约一半的套细胞淋巴瘤在主要易位簇中显示出bcl-1断裂。该检测在甲醛固定和石蜡包埋的材料中表现良好,可用于研究大量套细胞淋巴瘤的回顾性病例。